Dogwood Therapeutics, Inc DWTX

1.36 (0.07) (4.90%) as of 25 Sep
Market cap
$48.6M
P/E
0.0×
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

248.89% (109.66%) (90.31%) (143.45%)
ROA
(84.81%) (38.50%) (29.47%) (40.68%)
ROIC
(29.46%) (25.57%) (26.54%) (41.22%)
Return on Tangible Assets
(440.56%) (659.52%) (227.34%) (439.16%)
Free Cash Flow per Share
(9.44) (3.14) (0.46) (0.44)
Free Cash Flow
(18.11) (15.62) (15.52) (15.11)
Piotroski F-Score
3.00 2.00 2.00 2.00
Other line items
Cash ROIC
(20.70%) (19.18%) (16.54%) (19.38%)
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00
Tax Rate
0.01 0.01 0.00 (0.06)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.45 0.44 0.55 0.42
Depreciation/Fixed assets
8.17 4.25 0.00 0.00
Capex/Depreciation
0.00 0.00 — —
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(9.44) (3.14) (0.46) (0.44)
Capex per Share
0.00 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates